Tarina Fe 1/20 Eq Kit
Product Images NDC 50102-228

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tarina Fe 1/20 Eq (NDC 50102-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Norethindroneethinyl Fig1)

This is a table that shows the mortality rates per 100,000 woman years due to circulatory disease among women, categorized by age, smoking status, and oral contraceptive use. The table includes mortality rates for ever-users who don't smoke and controls who don't smoke, as well as ever-users who smoke and controls who smoke. The age ranges presented in the table are 15-24 years, 25-34 years, and 35-44 years. The data is adapted from a reference by P.M. Layde and V. Beral.*

FDA Label Image

Figure-2 (Norethindroneethinyl Fig2)

This is a set of data on the effect estimate of different studies pertaining to the use of combined oral contraceptives (COC) on women's health. The studies compare the risks associated with ever using or never using COC or current use versus never-use. The data includes various measurements such as odds ratios (OR), relative risks (RR), and hazard ratios (HR), as well as confidence intervals. The data suggests that there may be some slight increase or decrease in risk associated with COC use depending on the study, but overall the results are inconclusive.*

FDA Label Image

Figure-3 (Norethindroneethinyl Fig3)

This appears to be a set of instructions for a birth control pill pack. The pack allows for two different "start" options, one for those who begin their menstrual cycle on Sunday and one for those who start on another day. The pack is organized into four weeks with corresponding pills to be taken each day. The text advises taking the pills from left to right each week and reminds the user to consult with their doctor before taking any new medications.*

FDA Label Image

Figure-4 (Norethindroneethinyl Fig4)

This appears to be a set of instructions related to taking birth control pills according to a weekly cycle. It provides guidance on how to label and start the pills depending on the day of the week when the period starts. The text also contains a table to keep track of the weeks and advises taking pills in a specific direction each week.*

FDA Label Image

Figure-5 (Norethindroneethinyl Fig5)

FDA Label Image

Norethindroneethinyl Fig6

FDA Label Image

Chemical Structure (Norethindroneethinyl Str1)

FDA Label Image

Chemical Structure (Norethindroneethinyl Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.